Mitchell E. Levinson - Aug 19, 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Signature
/s/ Sandra Gardiner, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Aug 19, 2021
Transactions value $
$0
Form type
4
Date filed
8/20/2021, 04:22 PM
Previous filing
May 21, 2021
Next filing
Mar 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +65.5K $0.00 65.5K Aug 19, 2021 Common Stock 65.5K $21.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares subject to the option will vest in equal annual installments on the second, third and fourth anniversary of the grant date, and the other 50% of the shares subject to the option will vest upon the achievement of performance objectives established by the Compensation Committee of the Issuer, with vesting targets set at 25% (8,188 option shares) over the following four years on the anniversary of the grant date. All vesting is subject to the Reporting Person's continued service through each vesting date.